Product NDC: | 0409-2776 |
Proprietary Name: | Milrinone Lactate |
Non Proprietary Name: | Milrinone Lactate |
Active Ingredient(s): | 200 ug/mL & nbsp; Milrinone Lactate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2776 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075885 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020528 |
Package NDC: | 0409-2776-23 |
Package Description: | 10 BAG in 1 CASE (0409-2776-23) > 100 mL in 1 BAG |
NDC Code | 0409-2776-23 |
Proprietary Name | Milrinone Lactate |
Package Description | 10 BAG in 1 CASE (0409-2776-23) > 100 mL in 1 BAG |
Product NDC | 0409-2776 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Milrinone Lactate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20020528 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | MILRINONE LACTATE |
Strength Number | 200 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |